Apr 14, 2021
CAPE TOWN, SA / ACCESSWIRE / April 14, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("Wuhan" or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the followin...
Apr 9, 2021
CAPE TOWN, SA / ACCESSWIRE / April 9, 2021 / WUHAN GENERAL GROUP, INC. (OTC:WUHN) ("Wuhan" or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following upda...
Mar 23, 2021
This press release replaces the press release disseminated March 23rd, 2021 at 12:15 PM ET. The press release was missing the fifth paragraph. The corrected press release is below:
Mar 23, 2021
CAPE TOWN, SA / ACCESSWIRE / March 23, 2021 / WUHAN GENERAL GROUP, INC. (WUHN) ("Wuhan'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to announce today that the Co...
Mar 22, 2021
CAPE TOWN, SA / ACCESSWIRE / March 22, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("Wuhan'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to announce today th...
Feb 9, 2021
CAPE TOWN, SA / ACCESSWIRE / February 9, 2021 / WUHAN GENERAL GROUP, INC. (WUHN) ("Wuhan'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following upda...